FDA Adverse Event Injury Summary report: N

UNIVERS APEX HUMERAL STEM, SIZE 5

MDR report key: 23136077 · Received September 24, 2025

Report

Report Number
1220246-2025-04122
Event Type
Injury
Date Received
September 24, 2025
Date of Event
July 22, 2025
Report Date
November 11, 2025
Manufacturer
ARTHREX, INC.
Product Code
KWS
PMA / PMN Number
K153115
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: B5, D1, D2A, D2B, D4, G3, G4.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: D6A, D6B, G3, H3, H6. BASED ON THE INFORMATION PROVIDED WHICH MAY INCLUDE THE DEVICE (IF AVAILABLE AND RETURNED), PICTURES, VIDEOS, EVENT DESCRIPTION, AND ANY ADDITIONAL INFORMATION FROM THE FIELD, ARTHREX WAS ABLE TO CONCLUDE A MOST LIKELY CAUSE. THE MOST LIKELY CAUSE IS A PATIENT-SPECIFIC EVENT AS THE PATIENT UNDERWENT A REVISION SURGERY.

Additional Manufacturer Narrative · 0

INVESTIGATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE PROVIDED UPON AVAILABILITY OF ADDITIONAL INFORMATION.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS RECEIVED ON 9/25/2025: IT WAS CONFIRMED THAT THE PATIENT UNDERWENT REVISION SURGERY ON (B)(6) 2025 DURING WHICH AN AR-9100-05S ARTHREX UNIVERS HUMERAL STEM, AR-9106-01 ARTHREX UNIVERS VAULTLOCK GLENOID, AND AR-9145-15 ARTHREX UNIVERS HUMERAL HEAD WERE REMOVED. THE SURGERY WAS COMPLETED USING NEW ARTHREX IMPLANTS.

Description of Event or Problem · 0

ON 9/9/2025, A CLINDEX NOTIFICATION WAS RECEIVED REGARDING A PATIENT LISTED IN THE SHOULDER ARTHROPLASTY REGISTRY. THE PATIENT HAD RETURNED TO THE CLINIC ON (B)(6) 2025 DUE TO PAIN AND FUNCTIONAL LIMITATIONS. A CT SCAN WAS ORDERED AND REVIEWED. BASED ON IMAGING AND CLINICAL EXAMINATION, A ROTATOR CUFF TEAR WAS DIAGNOSED. THE RECOMMENDED TREATMENT WAS REVISION TO REVERSE SHOULDER ARTHROPLASTY, AND SURGERY WAS SCHEDULED FOR ON (B)(6) 2025. THIS EVENT WAS DETERMINED TO BE UNRELATED TO THE UNIVERS REVERS APEX IMPLANT PLACED ON (B)(6) 2017. ADDITIONAL INFORMATION RECEIVED ON 9/17/2025: DURING THE INITIAL SHOULDER ARTHROPLASTY, THE FOLLOWING IMPLANTS WERE USED: AR-9100-05S ARTHREX UNIVERS HUMERAL STEM, AR-9106-01 ARTHREX UNIVERS VAULTLOCK GLENOID, AND AR-9145-15 ARTHREX UNIVERS HUMERAL HEAD. POSTOPERATIVELY, THE PATIENT EXPERIENCED SYMPTOMS THAT WERE INITIALLY MANAGED WITH CONSERVATIVE MEASURES, INCLUDING PHYSICAL THERAPY AND NSAID USE AS NEEDED. WHEN SYMPTOMS PERSISTED DESPITE THESE INTERVENTIONS, A CT SCAN WAS PERFORMED, REVEALING SUPRASPINATUS ATROPHY AND A ROTATOR CUFF TEAR. BASED ON THESE FINDINGS, IT WAS DETERMINED THAT REVISION FROM TOTAL SHOULDER ARTHROPLASTY TO REVERSE SHOULDER ARTHROPLASTY WOULD BE THE MOST APPROPRIATE TREATMENT. THE RSA REVISION PROCEDURE WAS COMPLETED ON (B)(6) 2025. IT WAS NOT CONFIRMED IF ANY PRODUCTS WERE EXPLANTED. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2384334 UNIVERS APEX HUMERAL STEM, SIZE 5 PROSTHESIS, SHOULDER, CEMENTED KWS ARTHREX, INC. UNIVERS APEX HUMERAL STEM, SIZE 5 10036030

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other